These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23292863)
1. CD147, MMP9 expression and clinical significance of basal-like breast cancer. Liu Y; Xin T; Jiang QY; Huang DY; Shen WX; Li L; Lv YJ; Jin YH; Song XW; Teng C Med Oncol; 2013 Mar; 30(1):366. PubMed ID: 23292863 [TBL] [Abstract][Full Text] [Related]
2. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients. Zhao S; Ma W; Zhang M; Tang D; Shi Q; Xu S; Zhang X; Liu Y; Song Y; Liu L; Zhang Q Med Oncol; 2013 Mar; 30(1):335. PubMed ID: 23263825 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma. Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147 [TBL] [Abstract][Full Text] [Related]
4. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer. Xu XY; Lin N; Li YM; Zhi C; Shen H Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236 [TBL] [Abstract][Full Text] [Related]
5. CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer. Liu M; Tsang JYS; Lee M; Ni YB; Chan SK; Cheung SY; Hu J; Hu H; Tse GMK J Clin Pathol; 2018 Nov; 71(11):1007-1014. PubMed ID: 30099407 [TBL] [Abstract][Full Text] [Related]
6. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer. Xue YJ; Lu Q; Sun ZX Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007 [TBL] [Abstract][Full Text] [Related]
7. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer. Liu J; Ping W; Zu Y; Sun W Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249 [TBL] [Abstract][Full Text] [Related]
8. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis]. Zhou S; Liu C; Wu SM; Wu RL Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819 [TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer. Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. Liu Z; Li L; Yang Z; Luo W; Li X; Yang H; Yao K; Wu B; Fang W BMC Cancer; 2010 Jun; 10():270. PubMed ID: 20534121 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer. Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349 [TBL] [Abstract][Full Text] [Related]
12. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Yu W; Liu J; Xiong X; Ai Y; Wang H Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433 [TBL] [Abstract][Full Text] [Related]
13. CD147 expression indicates unfavourable prognosis in prostate cancer. Han ZD; Bi XC; Qin WJ; He HC; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Chen ZN; Zhong WD Pathol Oncol Res; 2009 Sep; 15(3):369-74. PubMed ID: 19048397 [TBL] [Abstract][Full Text] [Related]
14. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer. Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of basal cytokeratin expression in breast cancer. Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953 [TBL] [Abstract][Full Text] [Related]
16. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival. Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177 [TBL] [Abstract][Full Text] [Related]
17. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer. de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207 [TBL] [Abstract][Full Text] [Related]
18. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer. Ren X; Yuan L; Shen S; Wu H; Lu J; Liang Z Tumour Biol; 2016 Aug; 37(8):11385-95. PubMed ID: 26968553 [TBL] [Abstract][Full Text] [Related]
19. Expression of IFN-induced 2'-5'-oligoadenylate synthetases correlates with immune infiltration, revealing potential targets and new biomarkers for basal-like breast cancer prognosis. Zhao J; Zhang X; Cheng M; Guan J; Gai J; Fu L; Zhang R; Du T; Li Q Int Immunopharmacol; 2020 Nov; 88():106916. PubMed ID: 32882665 [TBL] [Abstract][Full Text] [Related]
20. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study. Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]